The An initial step in the mechanism of steroid hormone action involves binding of the steroid to receptor proteins in the target cell. The resulting complex then migrates into the cell nucleus and is thought to act as a modulator of gene expression (for review, see refs. 1-3). However, the actual biochemical function of the receptor remains unknown. This is the case because little is known about the regulation of gene activity in higher organisms, and also, because of difficulties in the purification and characterization of the receptor proteins. Some insight into the function of steroid receptors might be gained by studying their ability to interact with various cellular constituents. This approach has been used with the avian progesterone receptor to demonstrate its ability to bind to DNA and chromatin (4). Possible interactions between the receptor and other cellular constituents are difficult to analyze, particularly if the ligand is of a common type and of low molecular weight. Highly purified receptor preparations are not yet available for direct binding studies.
cAMP. A clear specificity for binding ATP was evident from these studies. When ATP was added to receptor preparations, the nucleotide did not affect the sedimentation properties or hormone binding characteristics of the receptor. Although the function of ATP remains unknown, these studies indicate a role of this nucleotide in some aspect of hormone receptor activity.
An initial step in the mechanism of steroid hormone action involves binding of the steroid to receptor proteins in the target cell. The resulting complex then migrates into the cell nucleus and is thought to act as a modulator of gene expression (for review, see refs. 1-3). However, the actual biochemical function of the receptor remains unknown. This is the case because little is known about the regulation of gene activity in higher organisms, and also, because of difficulties in the purification and characterization of the receptor proteins.
Some insight into the function of steroid receptors might be gained by studying their ability to interact with various cellular constituents. This approach has been used with the avian progesterone receptor to demonstrate its ability to bind to DNA and chromatin (4) . Possible interactions between the receptor and other cellular constituents are difficult to analyze, particularly if the ligand is of a common type and of low molecular weight. Highly purified receptor preparations are not yet available for direct binding studies.
We have used affinity chromatography as a relatively unambiguous and direct procedure for measuring the possible interaction of progesterone receptors with various nucleotides. While a role of nucleotides in the initial steps of hormone action is not directly evident, previous studies (5-7) indicate: (i) that energy-requiring or enzymatic steps may be involved in activation of the hormone-receptor complex and its translocation to nuclear sites of actions, and (ii) that this nuclear action is closely associated with the process of RNA synthesis. In addition, there have been a few reports that implicate a relationship between steroid receptors and ATP (see Discussion).
The present results show a specific binding between the progesterone receptor and ATP, suggesting an involvement of this nucleotide in some aspect of receptor function.
MATERIALS AND METHODS
All reagents were of analytical grade and were made up in glass-distilled water. All Preparation of A TP-Sepharose. ATP was covalently bound to Sepharose-4B by the method of Lamed et al. (8) . With this procedure, adipic acid dihydrazide is attached to CNBractivated Sepharose. ATP is oxidized by periodate and then linked to the Sepharose hydrazide. The ribose of ATP is, therefore, attached to Sepharose through the 6-carbon bridge of adipic acid dihydrazide. This method was chosen because it is relatively simple and unreacted hydrazide groups on the Sepharose do not have ion-exchange properties at neutral or high pH (8) .
The method adopted for activating Sepharose 4B by CNBr was that of Sica et al. (9) . The activated Sepharose was suspended in 1 volume of a cold, saturated solution of adipic acid dihydrazide (90 g/liter) in 0.1 M sodium acetate (pH 9.5), according to the method of Lamed et al. (8) . The reaction was allowed to proceed overnight (16-20 hr) at 40 with shaking. The Sepharose-hydrazide gel was washed thoroughly with 1.0 liter of water and 1.0 liter of NaCl (0.2 M) to remove unbound dihydrazide.
ATP was oxidized with sodium metaperiodate according to the method of Gilham (10) . To 10 ml of Sepharose-hydrazide preparation in 0.1 M sodium acetate buffer (pH 5) were added 70 ,umol of periodate-oxidized ATP in a total volume of 25 ml of 0.1 M\I sodium acetate, pH 5.0 (8) . The suspension was placed in a shaker for 3 hr at 40, after which 2 M NaCl (75 ml) was added and shaking was continued for another 30 min. This suspension was filtered under reduced pressure and washed with 1.0 liter of distilled water and 10Q ml of TETG buffer (50 mM Tris* HCl, 1 mM EDTA, 12 mM thioglycerol, pH 8.0). The preparation was stored in 40% glycerol at -200. To quantitate the amount of ATP per ml, 0.1 ml portions of the Sepharose were first oxidized by suspension in 1 ml of 7% perchloric acid/4.5 M H2SO4 and incubation for 60 min at 2400. The liquid was then analyzed for total phosphorus (11) . In our preparations, 1 ml of Sepharose contained 2 /Amol of ATP.
Preparation of Progesterone Receptor. Freshly excised oviducts from White Leghorn hens were obtained from a local produce company. The tissue was rinsed with cold 0.9% saline and homogenized in a Waring blender and then a "Tissumizer" (Tekmar model SDT) in two volumes (w/v) of TETG buffer with 20% glycerol (v/v), pH 8.0. The homogenate was centrifuged first at 12,000 X g for 10 min and then at 150,000 X g for 1 hr. Saturated (NH4)2SO4 (pH 7.5) was added to the cytosol to give a final concentration of 35% saturation. The suspension was stirred for 20 min at 40 and centrifuged at 12,000 X g for 10 min. The resulting pellets, containing the progesterone receptor, were stored at -70°.
Sucrose Gradient Analysis. Linear 5-20% sucrose gradients (4.5 ml) in TETG buffer were prepared with a Beckman Gradient Former. The gradients also contained 0.01 M KCl and, where indicated, 0.2 mM ATP. The receptor pellets were dissolved in TETG buffer, pH 8.0, in one-tenth the original cytosol volume before use. The preparations were incubated for 3 hr with 6 nM [3H progesterone before layering. Samples (0.2 ml) with and without ATP (0.2 mM) were layered onto the gradients, which were then centrifuged at 150,000 X g for 16 hr.
[14C]Ovalbumin (12) was layered on a separate gradient as a standard for the determination of sedimentation coefficients (13 (Fig. 1B-D further studies (data not shown), we found that free [3H]progesterone was not retained by the ATP column. Also, when the material in the peak fractions eluted from the ATP column with 1 M KCl was chromatographed on small Sephadex G-75 columns, the [3H]progesterone was bound to macromolecules. Samples of the peak fraction material were further tested by sucrose gradient centrifugation (Fig. 2) . This technique shows the hormone to be bound in a complex that sediments at about 4 S ( Fig. 2A) and is comparable to the major peak of binding activity in the preparation before chromatography (Fig. 2B) . The selectivity of the ATP-Sepharose column is illustrated in Fig. 1C, which Further studies on the use of this technique for the purification of progesterone receptors will be reported elsewhere.
To prove that an interaction between the receptor and ATP was occurring, the following experiment was performed. Two receptor samples were fractionated on parallel affinity columns. The samples were identical except that one contained 1 mM ATP. One would expect this ATP to competitively reduce the binding of receptors to the ATPSepharose (nucleotide concentration, 2 mM), and this was found to be the case (Fig. 1D ). The addition of higher ATP concentrations (>5 mM) generally blocks all binding of the hormone-receptor complex to ATP-Sepharose.
The competition analysis shown above was used to test the specificity of nucleotide binding by the progesterone-receptor complex. The experimental procedure was identical to that in the legend of Fig. 1D, except Since the above results suggest a role of ATP in some aspect of receptor function, attempts were made to describe any gross effects of ATP on the progesterone-receptor complex. 2 nM) . A 1000-fold excess of unlabeled progesterone was used in duplicate aliquots to account for nonspecific binding (which has been subtracted).
After a 3 hr incubation at 40, bound ['Hiprogesterone was determined by charcoal adsorption.
receptor in sucrose gradients in the presence or absence of ATP. Under low ionic conditions, the receptor in cytosol from either the chick or hen oviduct sedimented primarily as a 7S component (data not shown). However, after (NH4)2-S04 fractionation, the major receptor peak was in the 4S region of the sucrose gradient, often with a leading shoulder of heavier binding material (Fig. 2B) . In several experiments, this sedimentation pattern was not significantly altered by the addition of ATP.
The presence of ATP did not appear to cause any detectable effect on hormone binding (Fig. 3) . A series of samples was incubated with a fixed concentration of [3H progesterone together with varying concentrations of ATP. The extent of hormone binding was then determined by the charcoal adsorption assay. The binding was found to be quite stable throughout a 50-fold range of ATP concentration.
DISCUSSION
The present results demonstrate an interaction between the avian progesterone receptor and ATP which appears to be of a relatively high affinity and specificity. The detection of this ATP binding in crude receptor preparations was made possible by the use of affinity chromatography. This procedure is now well established as a method of protein purification and characterization (18, 19) .
The importance of nucleotides as enzyme cofactors in numerous biological systems has led, in recent years, to their application in affinity chromatography. In most cases, the immobilized nucleotides have been used as a step in enzyme purification (8, (20) (21) (22) (23) (24) (25) . They have also been used as characterization tools for studies such as the phosphorylation of succinyl CoA synthetase (24) and the interaction between myosin species and ATP (25) . The present studies illustrate another very useful application of affinity chromatography as a tool for identifying possible interactions between proteins and effectors or metabolites.
There are only a few published reports that suggest a possible relationship between steroid hormone receptors and ATP. Recently, Ishii and Aronow (26) reported that the glucocorticoid receptor from mouse fibroblasts could be stabilized by the addition of certain glucose metabolites, such as glucose-i-phosphate and glucose-6-phosphate, and, to a In other studies, Munck and coworkers (27, 28) found that the glucocorticoid receptor activity in rat thymus cells depended upon the levels of cellular ATP. When cells were incubated under anaerobic conditions, hormone binding decreased very significantly, as did the ATP concentration. This effect could be reversed by transfering the cells to aerobic conditions for a brief period. However, the low binding activity found in the cytosol extract of ATP-depleted cells could not be stimulated simply by the addition of ATP to the cytosol.
An effect of ATP on the nuclear transfer of estrogen receptors was reported by King et al. (29) , using a cell-free system from rat uteri. The nuclear binding of estradiolreceptor complex was measured after the incubation of receptor extract with isolated nuclei. They found that nuclear receptor binding was enhanced if the nuclei were incubated with ATP. A clear explanation for this effect was not provided. These investigators also reported that the addition of ATP precipitated the nuclear, but not the cytosol, estrogen receptor. However, this effect was not specific for ATP, but occurred as well with CTP and cAMP.
In a negative sense, Schaumburg (30) reported that ATP had no effect in stabilizing the glucocorticoid-binding protein from rat thymocytes. Also, it has been reported that ATP had no effect on the nuclear uptake of [3H]dexamethasonereceptor complex from rat liver using a cell-free system (31, 32) .
Little is known about the physicochemical properties of receptor-ATP interaction. The binding affinity would appear to be quite high since the complex can withstand nonequilibrium conditions for a considerable period of time. The binding appears to be of an ionic nature and is disrupted by high-salt conditions. This observation also indicates that, under the conditions used, the interaction is reversible. Further studies have shown that the receptor can be chromatographed on ATP-Sepharose repeatedly, indicating that no portion of the ATP molecule is being covalently linked to the receptor. However, it is possible that a covalent attachment would occur under appropriate conditions, for example, in the presence of free (unmodified) ATP or divalent cations. Preliminary results show that divalent cations have little effect on the binding of the progesterone receptor to ATP-Sepharose. However, these ions may be involved in a subsequent reaction of the receptor and ATP. Studies are also in progress to determine any role of progesterone in modi-fying the receptor-ATP interaction. In a qualitative sense, the receptor will bind to ATP-Sepharose in the absence of progesterone. However, whether or not the hormone influences this binding remains unknown.
At the present time there are no real indications as to the role of ATP in receptor function. ATP does not dramatically alter either the structure of the receptor or its ability to bind progesterone. One could envision a role of ATP as an energy source in either of two stages of receptor activity: (i) the translocation of receptors from a soluble or cytoplasmic phase to sites on the nuclear chromatin, and (ii) the presumed, but unknown, regulatory function of the receptor located on nuclear chromatin. Munck and coworkers (27, 28) 
